Stem-cell research: After the gold rush
By Peter Aldhous,
Nature
| 04. 07. 2005
California's voters have authorized the spending of $3 billion over the next decade on stem-cell research. But will this bonanza bring threats as well as opportunities? Peter Aldhous weighs the hopes and fears.
Click for larger map
Bob Klein is a man in a hurry. This energetic 59-year-old entrepreneur rose to public prominence last year, spearheading the campaign that convinced California's voters to back an audacious plan to create a $3-billion public fund to advance research on human stem cells. Interviewed by Nature in late February, he was determined to press ahead as soon as possible: "My goal would be to approve the first grants in May."
But today Klein and his supporters are wrestling with the practical realities of building their multibillion-dollar research agency, called the California Institute for Regenerative Medicine (CIRM), from scratch, while fending off political and legal attacks from both long-standing opponents and former allies. It's already clear that Klein's May deadline will be missed by several months.
Stem-cell biologists are looking forward to the injection of funds, whenever it finally arrives. But some question whether...
Related Articles
Riquet Mammoth Kakao (c.1920)
by Ludwig Hohlwein, Public Domain via Flickr
Colossal, the de-extinction company, scored headlines (1, 2, 3, 4, 5) recently by announcing that they had created mice! Not just any mice, not even colossal mice, but genetically engineered, normal-size “woolly mice” that are the result of editing seven genes in mouse embryos. This Colossal presented as an important step toward making a specimen of charismatic megafauna – a...
By Antonio Regalado, MIT Technology Review | 05.06.2024
It was a cool morning at the beef teaching unit in Gainesville, Florida, and cow number #307 was bucking in her metal cradle as the arm of a student perched on a stool disappeared into her cervix. The arm held...
By Gregory E. Kaebnick, STAT | 09.15.2023
Ian Wilmut, the British scientist behind the first-ever cloning of a mammal, died Sept. 10, leaving behind a twofold legacy. One part is groundbreaking science. Creating Dolly required a combination of genome manipulation and reproductive tools that helped launch what...
Poster for King of Clones (Netflix documentary) via Wikipedia
Back in the early years of this century, the most prominent rogue in biotech was a South Korean scientist named Hwang Woo-Suk. He became one of the best-known scientists in the world, and achieved rock-star status in Korea, when he reported his success using human cloning to create embryonic stem cells. Not long thereafter it was revealed that he had faked his results, triggering a new round of global headlines and...